According to Takara Bio's latest financial reports the company's current revenue (TTM ) is $0.29 Billion USD. In 2023 the company made a revenue of $0.33 Billion USD a decrease over the revenue in the year 2022 that were of $0.62 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | $0.29 B | -12.86% |
2023 | $0.33 B | -45.45% |
2022 | $0.62 B | 12.01% |
2021 | $0.55 B | 48.72% |
2020 | $0.37 B | 18.26% |
2019 | $0.31 B | -2.08% |
2018 | $0.32 B | 15.56% |
2017 | $0.27 B | 2.17% |
2016 | $0.27 B | 12.27% |
2015 | $0.24 B | 5.09% |
2014 | $0.23 B | 0.35% |
2013 | $0.23 B | -5.87% |
2012 | $0.24 B | 1.82% |
2011 | $0.24 B | 11.4% |
2010 | $0.21 B | 7.24% |
2009 | $0.20 B |